Tata India Pharma & HealthCare Fund Growth Return

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
This Fund:
Sensex:
BankFD:

Showing Funds Performance since Sep 07, 2020

Tata India Pharma & HealthCare Fund Growth Fund Overview

Min. investment

SIP ₹100 & Lump. ₹5000

AUM (Fund size)

₹1,499 Cr

Lock In Period

N/A

Expense Ratio

2.37

Exit Load

0.25% of NAV if redeemed/switched out before 30 days from the date of allotment.

Benchmark

BSE Healthcare Total Return

Tata India Pharma & HealthCare Fund Growth Calculate Returns

You would have got

close_grey_icon
No Data Found
Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5

Growth Review

DurationFund Return(%)Category Average(%)Category Best(%)
1M7.061.3010.65
6M5.603.1220.51
1Y8.204.1432.29
3Y16.8414.29124.36

Portfolio Analysis

  • Equity: 99.74%
  • Debt:
  • Others
As on: 2026-10-31
View allocation % by

1. SUN PHARMACEUTICAL INDUSTRIES LTD7.89%
2. ABBOTT INDIA LTD5.66%
3. DIVI LABORATORIES LTD5.41%
4. DR REDDYS LABORATORIES LTD5.14%
5. TORRENT PHARMACEUTICALS LTD4.73%
6. SAI LIFE SCIENCES LTD3.22%
7. SYNGENE INTERNATIONAL LTD3.17%
8. PROCTER & GAMBLE HEALTH LTD3.15%
9. LUPIN LTD3.13%
10. CIPLA LTD3.08%
11. ANTHEM BIOSCIENCES LTD2.99%
12. NATCO PHARMA LTD2.86%
13. FDC LTD2.69%
14. PFIZER LTD2.40%
15. ACUTAAS CHEMICALS LTD2.40%
16. BIOCON LTD2.23%
17. AJANTA PHARMA LTD1.59%
18. ALKEM LABORATORIES LTD1.40%
19. GLAXOSMITHKLINE PHARMACEUTICALS LTD0.69%
20. ZIM LABORATORIES LTD0.57%
21. SYMBIOTEC PHARMALAB LTD0.48%
22. IPCA LABORATORIES LTD0.00%

1. HEALTHCARE GLOBAL ENTERPRISES LTD5.25%
2. APOLLO HOSPITALS ENTERPRISE LTD4.55%
3. MAX HEALTHCARE INSTITUTE LTD4.28%
4. RAINBOW CHILDRENS MEDICARE LTD4.02%
5. ASTER DM QUALITY CARE LTD2.33%
6. DR. AGARWALS HEALTH CARE LTD1.31%
7. MANIPAL HEALTH ENTERPRISES LTD0.57%
8. MOLBIO DIAGNOSTICS LTD0.53%
9. DR. LAL PATH LABS LTD0.03%

1. BAYER CROPSCIENCE LTD2.68%
2. SUMITOMO CHEMICAL INDIA LTD1.01%
3. PI INDUSTRIES LTD0.46%

1. SANOFI CONSUMER HEALTHCARE INDIA LTD1.99%
2. GUJARAT FLUOROCHEMICALS LTD0.51%

1. NAVIN FLUORINE INTERNATIONAL LTD2.15%

1. GILLETTE INDIA LTD1.25%

1. NESTLE INDIA LTD1.09%
No Data Found
No Data Found

About Fund Tata India Pharma & HealthCare Fund Growth

Tata India Pharma & HealthCare Fund Growth managed by Tata Mutual Fund,is a Healthcare & Pharmascheme with Assets Under Management of ₹1,499 Crore. The fund benchmarks its performance against the BSE Healthcare Total Return while maintaining an expense ratio of 2.37. Under the expert guidance of Rajat Srivastava ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.

Fund Managers

Rajat Srivastava

Mr. Rajat Srivastava has done BBA (Banking & Insurance), PGDM - IMT Ghaziabad. Prior to joining Tata Mutual Fund, he has worked with Incred Asset Management, Kotak Investment Banking, Emkay Global, Evalueserve and Motilal Oswal Financial Services.

Tata India Pharma & HealthCare Fund Growth FAQs

Tata India Pharma & HealthCare Fund Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.

The expense ratio of Tata India Pharma & HealthCare Fund Growth is 2.37. This expense ratio is calculated by dividing the fund's operating expenses by its net assets.

Tata India Pharma & HealthCare Fund Growth’s fund performance is as follows:
  • 1 Month : 7.06%
  • 6 Months : 5.60%
  • 1 Year : 8.20%
  • 3 Years : 16.84%
Returns of Tata India Pharma & HealthCare Fund Growth are updated daily based on NAV of ₹ 33.2998 as on Nov 17,2026. Since inception, the return has been 59.52%.

You can invest in Tata India Pharma & HealthCare Fund Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.

The fund size (AUM) of Tata India Pharma & HealthCare Fund Growth is ₹1,499 crore. It changes based on market performance, inflows, and outflows.

You can track your investment in Tata India Pharma & HealthCare Fund Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.
  • Daily Research Calls
  • ₹0 AMC for First Year
  • Dedicated RM Support
Open a Free Demat Account
+ Free 1st Year AMC